No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Anti-Inflammatory Agents / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Anticholesteremic Agents / therapeutic use*
-
Biomarkers / blood
-
Carotid Arteries / diagnostic imaging
-
Carotid Arteries / drug effects*
-
Carotid Arteries / metabolism
-
Carotid Artery Diseases / blood
-
Carotid Artery Diseases / diagnostic imaging
-
Carotid Artery Diseases / drug therapy*
-
Cholesterol, LDL / blood
-
Double-Blind Method
-
Dyslipidemias / blood
-
Dyslipidemias / diagnosis
-
Dyslipidemias / diagnostic imaging*
-
Female
-
Fluorodeoxyglucose F18 / administration & dosage
-
Humans
-
Inflammation Mediators / blood
-
Male
-
Middle Aged
-
Netherlands
-
PCSK9 Inhibitors*
-
Positron Emission Tomography Computed Tomography
-
Radiopharmaceuticals / administration & dosage
-
Time Factors
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal, Humanized
-
Anticholesteremic Agents
-
Biomarkers
-
Cholesterol, LDL
-
Inflammation Mediators
-
PCSK9 Inhibitors
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18
-
PCSK9 protein, human
-
alirocumab